Article Text

Download PDFPDF
Delivering better value colonoscopy: bridging the gap with FIT
  1. Robert P H Logan1,
  2. Willie Hamilton2
  1. 1 Department of Gastroenterology, King's College Hospital, London, UK
  2. 2 Department of Primary Care, University of Exeter, Exeter, UK
  1. Correspondence to Dr Robert P H Logan, Medical Statistics Unit, Kings College Hospital, London, UK; robert.logan{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Colorectal cancer (CRC) survival is slowly improving in the Western world. To a considerable extent, this reflects earlier detection, either by a screening programme, or by earlier diagnosis in patients with symptoms. However, symptoms on their own are poor predictors of CRC, so this improvement comes at a cost – a considerable increase in the demand for colonoscopy – putting many endoscopy facilities under strain. So how can we deliver even better outcomes for patients at risk of CRC during, and after the COVID-19 pandemic?

The important paper from D’Souza et al in Gut adds to a growing body of research examining if Faecal Immunochemical Test (FIT)can be used to target colonoscopy to those patients most likely to harbour CRC and possibly obviate the need for colonoscopy in others.1 D’Souza et al report on the use of the HM-JACKarc assay, one of the most used assays in the UK. For this assay, the limit of quantitation (the lowest value for reliable clinical use) is 7 µg Hb/g, though the assay can detect values as low as 2 µg Hb/g, although with decreasing reliability.2 One strength of D’Souza et al’s paper is its large size, allowing examination of three possible definitions of a ‘positive’ test, as well as other demographic features, such as age, gender, deprivation and ethnicity. Unlike in previous studies, these four features transpired to have little predictive value, as other studies have also reported, though with small numbers in some of the …

View Full Text


  • Contributors Both authors made equal contributions in discussing, drafting and finalising the commentary.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles